Mika Nishimura has been a global medtech executive for 30 years and an operational partner with Gilde Healthcare since 2011. Gilde is a trans-Atlantic life science venture fund with $1.2 billion under management and a $460 million fund closed in 2020. We invest in late-stage companies in Europe and North America requiring significant capital (initial check size around $20 million).
As a member of the investment team, Mika is involved in due diligence and deal flow generation. She is also a valued advisor to portfolio companies given her extensive global commercialization experience.
Mika is attending / has attended:
Venture Summit Virtual Connect 3
Venture Summit Virtual Connect | Global 21
Venture Summit Virtual Connect 21